New Threads Only:  Add to Google Reader or Homepage
New Threads & Replies:  Add to Google Reader or Homepage
Forums are for serious investors only. GuruFocus Forum Rules.

Forum List » Business News and Headlines
SEC Filings, Earing Reports, Press Releases
New Topic Search
Goto Thread: PreviousNext
Goto: Forum ListMessage ListNew TopicSearchLog In
Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares
Posted by: gurufocus (IP Logged)
Date: December 1, 2010 04:35PM

CEO/CSO of Progenics Pharmaceuticals Inc. (PGNX) Paul J Maddon buys 5,000 shares of PGNX on 12/01/2010 at an average price of $4.9 a share.

Progenics Pharmaceuticals Inc. has a market cap of $155.8 million; its shares were traded at around $4.75 with and P/S ratio of 3.2. Progenics Pharmaceuticals Inc. had an annual average earning growth of 5.6% over the past 10 years.

PGNX is in the portfolios of Paul Tudor Jones of The Tudor Group, Jim Simons of Renaissance Technologies LLC.

CEO Recent Trades:


  • Buy: CEO/CSO Paul J Maddon bought 5,000 shares of PGNX stock on 11/01/2010 at the average price of 4.76. Paul J Maddon owns at least 849,057 shares after this. The price of the stock has decreased by 0.21% since.

  • Buy: CEO/CSO Paul J Maddon bought 5,000 shares of PGNX stock on 10/04/2010 at the average price of 4.99. Paul J Maddon owns at least 844,057 shares after this. The price of the stock has decreased by 4.81% since.

  • Buy: CEO/CSO Paul J Maddon bought 5,000 shares of PGNX stock on 09/01/2010 at the average price of 4.1. Paul J Maddon owns at least 839,057 shares after this. The price of the stock has increased by 15.85% since.

  • Buy: CEO/CSO Paul J Maddon bought 5,000 shares of PGNX stock on 08/02/2010 at the average price of 4.75. Paul J Maddon owns at least 834,057 shares after this. The price of the stock has decreased by 0% since.

  • Buy: CEO/CSO Paul J Maddon bought 5,000 shares of PGNX stock on 07/16/2010 at the average price of 4.99. Paul J Maddon owns at least 829,057 shares after this. The price of the stock has decreased by 4.81% since.


CFO Recent Trades:


  • Sell: CFO Robert A Mckinney sold 4,000 shares of PGNX stock on 06/18/2010 at the average price of 6.25. Robert A Mckinney owns at least 32,925 shares after this. The price of the stock has decreased by 24% since.


Directors and Officers Recent Trades:


  • Sell: VP, Research & Development William C Olson sold 2,364 shares of PGNX stock on 06/22/2010 at the average price of 5.81. William C Olson owns at least 35,494 shares after this. The price of the stock has decreased by 18.24% since.

  • Sell: Sr. VP, Medical Affairs Robert J Israel sold 6,180 shares of PGNX stock on 06/22/2010 at the average price of 5.82. Robert J Israel owns at least 31,186 shares after this. The price of the stock has decreased by 18.38% since.

  • Sell: Sr. VP, Product Dev. Thomas A Boyd sold 2,409 shares of PGNX stock on 06/22/2010 at the average price of 5.74. Thomas A Boyd owns at least 36,625 shares after this. The price of the stock has decreased by 17.25% since.

  • Sell: President Mark Robert Baker sold 2,328 shares of PGNX stock on 06/22/2010 at the average price of 5.66. Mark Robert Baker owns at least 26,689 shares after this. The price of the stock has decreased by 16.08% since.




Stocks Discussed: PGNX,
Rate this post:




Sorry, only registered users may post in this forum.

Please Login if you have an account or Create a Free Account if you don't




Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial